Genetic Susceptibility in Infectious Diseases

Biotechnology and Genetic Engineering Reviews

Volumn 17, Issue 1, 2000, Pages 255-266

  Thursz, Mark ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DNA SEQUENCES;

CANDIDATE LIST; COMPLEX TRAITS; DISEASE ASSOCIATIONS; DISEASE SUSCEPTIBILITY; GENETIC SUSCEPTIBILITY; GENOMIC ERA; INFECTIOUS DISEASE; INTERSPECIFIC CROSS; NUMBER OF FACTORS;

GENES;

ALLELE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DNA POLYMORPHISM; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOME; HEPATITIS B; HEPATITIS C; HERITABILITY; INFECTION; MULTIFACTORIAL INHERITANCE; PHENOTYPE; REVIEW;

HEPATITIS C VIRUS;

EID: 0034489099     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.1080/02648725.2000.10647994     Document Type: Article

References (47)

1. Alric, L., Fort, M., Izopet, J., Vinel, J. P., Charlet, J. P., Selves, J., Puel, J., Pascal, J. P., Duffaut, M. and Abbal, M. (1997). Genes of the major histocompatibility complex class U influence the outcome of hepatitis C virus infection. Gastroenterology 113, 1675-1681
2. Arguellq, J. R., Little, A. M., Pay, A. L., Gallardo, D., Rojas, I., Marsh, S. G., Goldman! J. M. and Madrigal, J. A. (1998). Mutation detection and typing of polymorphic loci through double-strand conformation analysis. Nature Genetics 18, 192-194
3. Bellamy, R., Ruwende, C., Corrah, T., Mcadam, K. P., Whittle, H. C. and Hill, A. V. (1998). Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. New England Journal of Medicine 338, 640-644
4. Bellamy, R., Ruwende, C., Corrah, T., Mcadam, K. P., Thursz, M., Whittle, H. C. and Hill, A. V. (1999). Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. Journal of Infectious Diseases 179 (3), 721-724
5. Blackwell, J. L. and Brinton, M. A. (1995). BHK cell proteins that bind to the 3' stem-loop structure of the West Nile virus genome RNA. Journal of Virology 69, 5650-5658
6. Brinton, M. A. (1982). Characterization of West Nile virus persistent infections in genetically resistant and susceptible mouse ceils. I. Generation of defective nonplaquing virus particles. Virology 116, 84-98
7. Brinton, M. A., Davis, J. and Schaefer, D. (1985). Characterization of West Nile virus persistent infections in genetically resistant and susceptible mouse cells. II. Generation of temperature-sensitive mutants. Virology 140, 152-158
8. Chiarelli, I., Porfirio, B., Mattiuz, P. L., Seri, M., Caroli, F., Celli, I., Romeo, G., Volorio, S. and Zollo, M. (1998). A method for point mutation analysis that links SSCP and dye primer fluorescent sequencing. Molecular and Cellular Probes 12, 125-131
9. Copeman, J., Cucca, F. and Hearne, C. (1995). Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene. Nature Genetics 9, 80
10. Cramp, M. E., Rossol, S., Carucci, P., Williams R., Naumov, N. V. and Donaldson, P. T. (1998). The Influence Of The Hla Class Ii Allele Dqb 10301 on HCV specific T helper cell responses. Journal of Hepatology 28, 94
11. Czaja, A. J., Carpenter, H., Santrach, P. J. and Moore, S. B. (1996). DR human leukocyte antigens and disease severity in chronic hepatitis C. Journal of Hepatology 24, 666-673
12. Darvasi, A. (1998). Experimental strategies for the genetic dissection of complex traits in animal models. Nature Genetics 18, 19-24
13. Freson, K., Peerlinck, K., Aguirre, T., Arnout, J., Vermylen, J., Cassiman, J. J. and Matthus, G. (1998). Fluorescent chemical cleavage of mismatches for efficient screening of the factor VIII gene. Human Mutation 11, 470-479
14. Giani, G., Chiaramonte, M., Pasini, C. V., Fagiolo, U. and Naccarato, R. (1979). Hepatitis B surface antigenaemia and HLA antigens. New England Journal of Medicine 300, 1056
15. Hohler, T., Gerken, G., Notghi, A., Lubjuhn, R., Taheri, H., Protzer, U., Lohr, H. F., Schneider, P. M., Meyer Zum Buschenfelde, K. H. and Rittner, C. (1997). Hla-Drbi*1301 and *1302 protect against chronic hepatitis B. Journal of Hepatology 26, 503-507
16. Hohler, T., Kruger, A., Gerken, G., Schneider, P. M., Meyer Zum Buschenefelde, K. H. and Rittner, C. (1998). A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clinical and Experimental Immunology 111, 579-582
17. Kong, A. and Cox, N. J. (1997). Allele-sharing models: LOD scores and accurate linkage tests. American Journal of Human Genetics 61, 1179-1188
18. Kroeger, K. M., Carville, K. S. and Abraham, L. J. (1997). The -308 tumor necrosis factoralpha promoter polymorphism effects transcription. Molecular Immunology 34, 391-399
19. Kuzushita, N., Hayashi, N., Katayama, K., Hiramatsu, N., Yasumaru, M., Murata, H., Shimizu, Y., Yamazaki, T., Fushimi, H., Kotoh, K., Kasahara, A., Fusamoto, H. and Kamada, T. (1996). Increased frequency of HLA DR 13 in hepatitis C virus carriers with persistently normal ALT levels. Journal of Medical Virology 48, 1-7
20. Lander, E. S. and Schork, N. J. (1994). Genetic dissection of complex traits [published erratum appears in Science 1994 Oct 21, 266 (5184), 353]. Science 265, 2037-2048
21. Lepage, V., Degos, F., Carella, G., De Lima, M., Giraud, M. C. and Degos, L. (1981). HLA-Cw-7 and HBsAg negative chronic active hepatitis. Tissue Antigens 18, 105-107
22. Lin, T. M., Ciien, C. J., Wu, M. M., Yang, C. S., Chen, J. S., Lin, C. C., Kwang, T. Y., Hsu, S. T., Lin, S. Y. and Hsu, L. C. (1989). Hepatitis B virus markers in Chinese twins. Anticancer Research 9, 737
23. Louis, E., Franchimont, D., Piron, A., Gevaert, Y., Schaaf Lafontaine, N., Roland, S., Mahieu, P., Malaìse, M., De Groote, D., Louis, R. and Belaiche, J. (1998). Tumour necrosis factor (TNF) gene poiymoiphism influences TNF-alpha production in Upopoly-saccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clinical and Experimental Immunology 113, 401-406
24. Mcguire, W., Hill, A. V. S., Allsopp, C. E., Greenwood, B. M. and Kwiatkowski, D. (1994). Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371, 508-510
25. Minton, E. J., Smillie, D., Neal, K. R., Irving, W. L., Underwood, J. C. and James, V. (1998). Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group. Journal of infectious Diseases 178 (1), 39-44
26. Mitchison, A. (1997). Partitioning of genetic variation between regulatory and coding gene segments: the predominance of software variation in genes encoding introvert proteins. hmnunogenetics 46, 46-52
27. Morrison, N. A., Qi, J. C., Tokita, A., Kelly, P. J., Crofts, L., Nguyen, T. V., Sambrook, P. N. and Eisman, J. A. (1994). Prediction of bone density from vitamin D receptor alleies. Nature 367, 284-287
28. Mota, A., Faìnboim, R., Terg, R. and Fainboim, L. (1987). Association of chronic active hepatitis and HLA-B35 in patients with hepatitis B virus. Tissue Antigens 30, 238-240
29. Muller, O., Minarik, M. and Foret, F. (1998). Ultrafast DNA analysis by capillary electrophoresis/laser-induced fluorescence detection. Electrophoresis 19, 1436-1444
30. Muniappan, B. P. and Thilly, W. G. (1999). Application of constant denaturant capillary electrophoresis (CDCE) to mutation detection in humans. Genetic Analysis 14, 221-227
31. Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R. and Levìn, M. (1996). A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacteria] infection. New England Journal of Medicine 335. 1941-1949
32. Poynard, T., Bedossa, P. and Opolon, P. (1997). Natural history of li ver fibrosis progression inpatients with chronic hepatitis C. The OBS VIRC, METAVIR, CLINIVIR, and DOS VIRC groups. The Lancet 349, 825-832
33. Reed, P., Davies, J. and Copeman, J. (1994). Chromosome-specific microsatellite sets for fluorescence-based, semi-automated genome mapping. Nature Genetics 7, 390
34. Rook, G. A., Taverne, J., Leveton, C. and Steele, J. (1987). The roie of Gamma interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 62, 229-234
35. Schurr, E., Skamene, E., Forget, A. and Gros, P. (1989). Linkage analysis of the Beg gene on mouse chromosome I, Identification of a tightly linked marker. Journal of Immunology 142, 4507-4513
36. Shi, P. Y., Li, W. and Brinton, M. A. (1996). Cell proteins bind specifically to West Nile virus minus-strand 3' stem-loop RNA. Journal of Virology 70, 6278-6287
37. Smith, B. C., Gorve, J., Guzail, M. A., Day, C. P., Daly, A. K., Burt, A. D. and Bassendine, M. F. (1998). Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27, 1695-1699
38. Taylor, G. R. and Deeble, J. (1999). Enzymatic methods for mutation scanning. Genetic Analysis 14, 181-186
39. Thursz, M. R., Kwiatkowski, D., Allsopp, C. E. M., Greenwood, B. M., Thomas, H. C. and Hill, A. V. S. (1995). Association between an MHC class II allele and clearance of hepatitis B virus in The Gambia. New England Journal of Medicine 332, 1065
40. Thursz, M., Y Allop, R., Goldin, R., Trepo, C. and Thomas, H. C. (1999). Influence of MHC class II genotype on outcome of infection with hepatitis C vims. Lancet 354 (9196). 2119-2124
41. Tong, M. J., El Farra, N. S., Reikes, A. R. and Co, R. L. (1995). Clinical outcomes after transfusion-associated hepatitis C. New England Journal of Medicine 332, 1463-1466
42. Urosevic, N., Mansfield, J. P., Mackenzie, J. S. and Shellam, G. R. (1995). Low resolution mapping around the flavivirus resistance locus (Flv) on mouse chromosome 5. Mammalian Genome 6, 454-458
43. Van Hattum, J., Schreuder, G. M and Schalm, S. (1987). HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 7, 11-14
44. Van Orsouw, NJ. and Vug, J. (1999). Design and application of 2-D DGGE-based gene mutational scanning tests. Genetic Analysis 14, 205-213
45. Weber, M. and May, P. (1989). Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. American Journal of Human Genetics 44, 388
46. Wilson, A. G., Devries, N., Pociot, F., Di Giovine, F. S., Van Der Putte, L. B. A. and Duff, G. W. (1993). An allelic polymorphism within the tumour necrosis alpha promotor region is strongly associated with HLA Al, B8, DR3 Aileles. Journal of Experimental Medicine 177 (2), 557-560
47. Wilson, A. G., Symons, J. A., Mcdowell, T. L., Mcdevitt, H. O. and Duff, G. W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United Stales of America 94, 3195-3199